University of South Florida Data Management and Coordinating Center
Welcome,         Profile    Billing    Logout  
 29 Trials 
33 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Merkel, Peter A
NCT02108860 / 2013-005535-24: Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)

Completed
3
65
Europe, Canada, US
Abatacept, CTLA4-Ig, Orencia, placebo
University of South Florida, The Cleveland Clinic, Bristol-Myers Squibb, University of Pennsylvania, National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Granulomatosis With Polyangiitis (Wegener's), Granulomatosis With Polyangiitis, Wegener's Granulomatosis, ANCA-Associated Vasculitis
07/23
12/23
NCT01933724: The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach

Active, not recruiting
3
12
US
5 mg prednisone, 5 mg glucocorticoids, 5 mg/day prednisone, 0 mg prednisone, no prednisone, no glucocorticoids
University of South Florida, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Office of Rare Diseases (ORD), National Center for Advancing Translational Sciences (NCATS), Rare Diseases Clinical Research Network
Granulomatosis With Polyangiitis, Wegener Granulomatosis, Vasculitis
12/25
12/25
NCT01940094: The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach

Completed
3
159
Canada, US
5 mg Prednisone, •5 mg/day glucocorticoids, •5 mg/day prednisone, •5 mg/day steroids, 0 mg Prednisone
University of Pennsylvania, National Heart, Lung, and Blood Institute (NHLBI), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Office of Rare Diseases (ORD), National Center for Advancing Translational Sciences (NCATS), Rare Diseases Clinical Research Network
Granulomatosis With Polyangiitis
12/24
12/24
OCEAN, NCT05263934 / 2021-005726-15: Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)

Recruiting
3
160
Europe, Canada, Japan, US, RoW
Depemokimab, Mepolizumab, Placebo matching mepolizumab, Placebo matching depemokimab
GlaxoSmithKline
Eosinophilic Granulomatosis With Polyangiitis
10/25
11/25
ABAGART, NCT04474847: Abatacept for the Treatment of Giant Cell Arteritis

Recruiting
3
78
Canada, US
Abatacept, CTLA4-Ig, Orencia, Placebo
University of Pennsylvania
Giant Cell Arteritis
12/29
12/29
LoDoNaVasc, NCT03482479: Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis

Recruiting
2
36
Canada, US
Naltrexone Hydrochloride, Placebo Comparator
University of Pennsylvania
Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS), Giant Cell Arteritis, Granulomatosis With Polyangiitis, Microscopic Polyangiitis, Polyarteritis Nodosa, Takayasu Arteritis
12/24
12/24
NCT05376319: PR3-AAV Resilient Remission or PRRR

Terminated
2
6
US
Obinutuzumab, Rituximab
Mayo Clinic, Genentech, Inc.
Granulomatosis With Polyangiitis, Microscopic Polyangiitis, ANCA Associated Vasculitis
05/24
05/24
NCT04919538: Longitudinal Study for Relapsing Polychondritis

Recruiting
N/A
100
US
University of Pennsylvania
Relapsing Polychondritis, Vasculitis
01/26
01/26
NCT00315380: Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis

Recruiting
N/A
700
Canada, US
University of Pennsylvania, GlaxoSmithKline, AstraZeneca
Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome
12/28
12/28
V-PREG, NCT02593565: Vasculitis Pregnancy Registry

Recruiting
N/A
100
US
Online questionnaires
University of Pennsylvania, Duke University, University of South Florida
Vasculitis, Behcet's Disease, CNS Vasculitis, Cryoglobulinemic Vasculitis, Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS), Granulomatosis With Polyangiitis (GPA), Wegener's Granulomatosis, IgA Vasculitis, Henoch-Schoenlein Purpura (HSP), Microscopic Polyangiitis (MPA), Polyarteritis Nodosa (PAN), Takayasu Arteritis (TAK), Urticarial Vasculitis, Systemic Vasculitis
12/25
12/26
NCT02967068: VCRC Tissue Repository

Recruiting
N/A
1000
Canada, US
University of Pennsylvania, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Center for Advancing Translational Sciences (NCATS), Office of Rare Diseases (ORD)
Aortitis, Cutaneous Vasculitis, Eosinophilic Granulomatosis With Polyangiitis, Giant Cell Arteritis, Granulomatosis With Polyangiitis (Wegener's), Henoch-Schonlein Purpura, IgA Vasculitis, Microscopic Polyangiitis, Polyarteritis Nodosa, Takayasu Arteritis, Churg-Strauss Syndrome
12/25
12/25
NCT05734404: Longitudinal Study for Central Nervous System Vasculitis

Recruiting
N/A
40
Canada, US
University of Pennsylvania, The Cleveland Clinic
Central Nervous System Vasculitis, CNS Vasculitis, CNSV, Vasculitis
12/26
12/26
NCT01241305: One-Time DNA Study for Vasculitis

Recruiting
N/A
1000
Canada, US, RoW
University of Pennsylvania, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Office of Rare Diseases (ORD), Rare Diseases Clinical Research Network
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis, Granulomatosis With Polyangiitis (Wegener's), Microscopic Polyangiitis, Polyarteritis Nodosa, Takayasu's Arteritis
08/27
08/27
Clowse, Megan E B
NCT00512694: Duke Lupus Registry

Recruiting
N/A
1000
US
Duke University
Systemic Lupus Erythematosus, Cutaneous Lupus
06/27
06/27
V-PREG, NCT02593565: Vasculitis Pregnancy Registry

Recruiting
N/A
100
US
Online questionnaires
University of Pennsylvania, Duke University, University of South Florida
Vasculitis, Behcet's Disease, CNS Vasculitis, Cryoglobulinemic Vasculitis, Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS), Granulomatosis With Polyangiitis (GPA), Wegener's Granulomatosis, IgA Vasculitis, Henoch-Schoenlein Purpura (HSP), Microscopic Polyangiitis (MPA), Polyarteritis Nodosa (PAN), Takayasu Arteritis (TAK), Urticarial Vasculitis, Systemic Vasculitis
12/25
12/26
HOP-STEP sIRB, NCT05818254: The HOP-STEP Intervention: Improving Maternal Health in Women With Lupus sIRB

Recruiting
N/A
20
US
HOP-STEP (Healthy Outcomes in Pregnancy with SLE Through Education of Providers) Intervention, Routine Care
Duke University, National Institutes of Health (NIH), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), University of Chicago
Systemic Lupus Erythematosus, Contraception
03/26
03/26
NCT03276923: Maternal Autoimmune Disease Research Alliance (MADRA) Registry

Recruiting
N/A
1000
US
Duke University
Autoimmune Diseases, Pregnancy Related, Systemic Lupus Erythematosus, Cutaneous Lupus, Rheumatoid Arthritis, Sjogren's Syndrome, Scleroderma
01/27
01/27
Barra, Lillian
FeMiTRA, NCT05790356: Fecal Microbial Transplantation for Rheumatoid Arthritis Trial

Recruiting
N/A
30
Canada
Fecal Microbial transplant, FMT Capsules, Placebo capsules, Placebo
Lawson Health Research Institute, St. Joseph's Health Care London
Arthritis, Arthritis, Rheumatoid, Fecal Microbiota Transplantation
08/25
04/26
BRAVO, NCT05716334: Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator

Active, not recruiting
N/A
201
Canada
McGill University Health Centre/Research Institute of the McGill University Health Centre, Sinai Health System, Lawson Health Research Institute, Hopital du Sacre-Coeur de Montreal, St. Joseph's Healthcare Hamilton, University of Calgary, University of British Columbia, University of Alberta, Ottawa Hospital Research Institute, CAnadian Network for Advanced Interdisciplinary Methods for comparative effectiveness research, Canadian Initiative for Outcomes in Rheumatology Care
ANCA-associated Vasculitis, Granulomatosis With Polyangiitis, Microscopic Polyangiitis
09/25
09/25
Pagnoux, Christian
NCT01940094: The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach

Completed
3
159
Canada, US
5 mg Prednisone, •5 mg/day glucocorticoids, •5 mg/day prednisone, •5 mg/day steroids, 0 mg Prednisone
University of Pennsylvania, National Heart, Lung, and Blood Institute (NHLBI), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Office of Rare Diseases (ORD), National Center for Advancing Translational Sciences (NCATS), Rare Diseases Clinical Research Network
Granulomatosis With Polyangiitis
12/24
12/24
OCEAN, NCT05263934 / 2021-005726-15: Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)

Recruiting
3
160
Europe, Canada, Japan, US, RoW
Depemokimab, Mepolizumab, Placebo matching mepolizumab, Placebo matching depemokimab
GlaxoSmithKline
Eosinophilic Granulomatosis With Polyangiitis
10/25
11/25
NCT02939573: A Randomized Multicenter Study for Isolated Skin Vasculitis

Recruiting
2
90
Canada, Japan, US
Colchicine, Colcrys, Dapsone, DDS, Diaminodiphenylsulfone, Azathioprine, Imuran
University of Pennsylvania, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Center for Advancing Translational Sciences (NCATS), Office of Rare Diseases (ORD)
Primary Cutaneous Vasculitis, Cutaneous Polyarteritis Nodosa, IgA Vasculitis, Henoch-Schönlein Purpura
12/25
12/25
PRAVDA, NCT04280601: PRagmatic Analysis of Vitamin D in ANCA-Associated Vasculitis

Completed
N/A
102
Canada
vitamin D
Christian Pagnoux
ANCA-associated Vasculitis, Granulomatosis With Polyangiitis, Microscopic Polyangiitis, Eosinophilic Granulomatosis With Polyangiitis
03/23
03/23
NCT00315380: Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis

Recruiting
N/A
700
Canada, US
University of Pennsylvania, GlaxoSmithKline, AstraZeneca
Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome
12/28
12/28
BRAVO, NCT05716334: Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator

Active, not recruiting
N/A
201
Canada
McGill University Health Centre/Research Institute of the McGill University Health Centre, Sinai Health System, Lawson Health Research Institute, Hopital du Sacre-Coeur de Montreal, St. Joseph's Healthcare Hamilton, University of Calgary, University of British Columbia, University of Alberta, Ottawa Hospital Research Institute, CAnadian Network for Advanced Interdisciplinary Methods for comparative effectiveness research, Canadian Initiative for Outcomes in Rheumatology Care
ANCA-associated Vasculitis, Granulomatosis With Polyangiitis, Microscopic Polyangiitis
09/25
09/25
NCT01241305: One-Time DNA Study for Vasculitis

Recruiting
N/A
1000
Canada, US, RoW
University of Pennsylvania, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Office of Rare Diseases (ORD), Rare Diseases Clinical Research Network
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis, Granulomatosis With Polyangiitis (Wegener's), Microscopic Polyangiitis, Polyarteritis Nodosa, Takayasu's Arteritis
08/27
08/27
Gipson, Debbie
NCT04009668: Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease

Completed
2
7
US
adalimumab, Humira
University of Michigan
FSGS, MCD, Focal Segmental Glomerulosclerosis, Minimal Change Disease
09/23
10/23
NEPTUNE, NCT01209000: Nephrotic Syndrome Study Network

Recruiting
N/A
1200
Canada, US
Kidney Biopsy
University of Michigan, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), The NephCure Foundation
Minimal Change Disease (MCD), Membranous Nephropathy, Glomerulosclerosis, Focal Segmental
06/26
06/26
NEPTUNE Match, NCT04571658: Study

Enrolling by invitation
N/A
375
US
Communication
University of Michigan, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Nephrotic Syndrome in Children, Focal Segmental Glomerulosclerosis, Minimal Change Disease, Minimal Change Nephrotic Syndrome, Membranous Nephropathy, FSGS, MCD, MCD - Minimal Change Disease
06/26
06/26
RESOLVE, NCT05650619: Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease

Recruiting
N/A
300
US
Biospecimen collection, Data collection
University of Michigan
Focal Segmental Glomerulosclerosis, Minimal Change Disease, FSGS, MCD
12/26
12/26
C-PROBE, NCT01016613: Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center

Recruiting
N/A
1800
US
University of Michigan, St. John Health System, Michigan, Temple University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Chronic Kidney Disease, Glomerulopathy
07/30
07/30
Prepare-NS, NCT05505500: Interview Study of Adult and Child Patients and Parents of Children with Swelling Due to Nephrotic Syndrome.

Recruiting
N/A
150
US
Interview
University of Michigan, Northwestern University, Food and Drug Administration (FDA)
Fluid Overload, Glomerulosclerosis, Focal Segmental, Edema, Membranous Nephropathy, Minimal Change Disease, Minimal Change Nephrotic Syndrome, IgM Nephropathy, Nephrotic Syndrome, Glomerular Disease, Nephrotic Syndrome, Minimal Change, Nephrotic Syndrome in Children, Nephrotic Syndrome with Edema (Diagnosis), FSGS
04/26
04/26
Burroughs, Cristina
V-PREG, NCT02593565: Vasculitis Pregnancy Registry

Recruiting
N/A
100
US
Online questionnaires
University of Pennsylvania, Duke University, University of South Florida
Vasculitis, Behcet's Disease, CNS Vasculitis, Cryoglobulinemic Vasculitis, Eosinophilic Granulomatosis With Polyangiitis (EGPA), Churg-Strauss Syndrome (CSS), Granulomatosis With Polyangiitis (GPA), Wegener's Granulomatosis, IgA Vasculitis, Henoch-Schoenlein Purpura (HSP), Microscopic Polyangiitis (MPA), Polyarteritis Nodosa (PAN), Takayasu Arteritis (TAK), Urticarial Vasculitis, Systemic Vasculitis
12/25
12/26

Download Options